High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.

H. Reyes,J. Miecznikowski,J. Gonzalez-Bosquet,E. Devor,Yuping Zhang,Kristina W. Thiel,M. Samuelson,M. Mcdonald,J. Stephan,P. Hanjani,S. Guntupalli,K. Tewari,F. Backes,N. Ramirez,G. Fleming
DOI: https://doi.org/10.1016/j.ygyno.2017.05.017
IF: 5.304
2017-08-01
Gynecologic Oncology
Abstract:
What problem does this paper attempt to address?